Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study

Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, Satoshi Yoshioka, Kazunori Imada, Kentaro Fukushima, Masaaki Hotta, Shin-ichi Fuchida, Junya Kanda, Nobuhiko Uoshima, Yuji Shimura, Hirokazu Tanaka, Kensuke Ohta, Satoru Kosugi, Hideo Yagi, Satoshi Yoshihara, Ryosuke Yamamura, Yoko Adachi, Hitoshi Hanamoto, Hirohiko Shibayama, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Akifumi Takaori-Kondo, Junya Kuroda, Itaru Matsumura, Masayuki Hino, Unknown

Open source

DOI: 10.1007/s00277-024-05705-z
Published: 2024-03-16
Container: Annals of Hematology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00277-024-05705-z,
  title = {Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study},
  author = {Naokazu Nakamura and Nobuyoshi Arima and Teruhito Takakuwa and Satoshi Yoshioka and Kazunori Imada and Kentaro Fukushima and Masaaki Hotta and Shin-ichi Fuchida and Junya Kanda and Nobuhiko Uoshima and Yuji Shimura and Hirokazu Tanaka and Kensuke Ohta and Satoru Kosugi and Hideo Yagi and Satoshi Yoshihara and Ryosuke Yamamura and Yoko Adachi and Hitoshi Hanamoto and Hirohiko Shibayama and Naoki Hosen and Tomoki Ito and Chihiro Shimazaki and Akifumi Takaori-Kondo and Junya Kuroda and Itaru Matsumura and Masayuki Hino and Unknown},
  year = {2024},
  journal = {Annals of Hematology},
  doi = {10.1007/s00277-024-05705-z},
  url = {https://doi.org/10.1007/s00277-024-05705-z}
}

RIS

TY  - JOUR
TI  - Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study
AU  - Naokazu Nakamura
AU  - Nobuyoshi Arima
AU  - Teruhito Takakuwa
AU  - Satoshi Yoshioka
AU  - Kazunori Imada
AU  - Kentaro Fukushima
AU  - Masaaki Hotta
AU  - Shin-ichi Fuchida
AU  - Junya Kanda
AU  - Nobuhiko Uoshima
AU  - Yuji Shimura
AU  - Hirokazu Tanaka
AU  - Kensuke Ohta
AU  - Satoru Kosugi
AU  - Hideo Yagi
AU  - Satoshi Yoshihara
AU  - Ryosuke Yamamura
AU  - Yoko Adachi
AU  - Hitoshi Hanamoto
AU  - Hirohiko Shibayama
AU  - Naoki Hosen
AU  - Tomoki Ito
AU  - Chihiro Shimazaki
AU  - Akifumi Takaori-Kondo
AU  - Junya Kuroda
AU  - Itaru Matsumura
AU  - Masayuki Hino
AU  - Unknown
PY  - 2024
JO  - Annals of Hematology
DO  - 10.1007/s00277-024-05705-z
UR  - https://doi.org/10.1007/s00277-024-05705-z
ER  -

APA

Nakamura, N., Arima, N., Takakuwa, T., Yoshioka, S., Imada, K., Fukushima, K., Hotta, M., Fuchida, S., Kanda, J., Uoshima, N., Shimura, Y., Tanaka, H., Ohta, K., Kosugi, S., Yagi, H., Yoshihara, S., Yamamura, R., Adachi, Y., Hanamoto, H., Shibayama, H., Hosen, N., Ito, T., Shimazaki, C., Takaori-Kondo, A., Kuroda, J., Matsumura, I., Hino, M., & Unknown (2024). Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study. Annals of Hematology. https://doi.org/10.1007/s00277-024-05705-z

Source records

crossref · retrieved 2026-09-27T02:46:17.582Z